112 related articles for article (PubMed ID: 17045123)
1. Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis.
Biedunkiewicz B; Lizakowski S; Tylicki L; Skiboeska A; Nieweglowski T; Chamienia A; Debska-Slizien A; Rutkowski B
Arch Med Res; 2006 Nov; 37(8):1034-7. PubMed ID: 17045123
[TBL] [Abstract][Full Text] [Related]
2. Fistula function and dialysis adequacy during ozonotherapy in chronically hemodialyzed patients.
Tylicki L; Biedunkiewicz B; Nieweglowski T; Grabowska M; Chamienia A; Slizien AD; Rutkowski B
Artif Organs; 2004 May; 28(5):513-7. PubMed ID: 15156869
[TBL] [Abstract][Full Text] [Related]
3. No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients.
Tylicki L; Biedunkiewicz B; Rachon D; Nieweglowski T; Hak L; Chamienia A; Debska-Slizien A; Aleksandrowicz E; Mysliwska J; Rutkowski B
Mediators Inflamm; 2004 Dec; 13(5-6):377-80. PubMed ID: 15770057
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study.
Biedunkiewicz B; Tylicki L; Nieweglowski T; Burakowski S; Rutkowski B
Int J Artif Organs; 2004 Jan; 27(1):29-34. PubMed ID: 14984181
[TBL] [Abstract][Full Text] [Related]
5. Hyperbaric oxygen, oxygen-ozone therapy, and rheologic parameters of blood in patients with peripheral occlusive arterial disease.
Verrazzo G; Coppola L; Luongo C; Sammartino A; Giunta R; Grassia A; Ragone R; Tirelli A
Undersea Hyperb Med; 1995 Mar; 22(1):17-22. PubMed ID: 7742706
[TBL] [Abstract][Full Text] [Related]
6. Can the combination of localized "proliferative therapy" with "minor ozonated autohemotherapy" restore the natural healing process?
Gracer RI; Bocci V
Med Hypotheses; 2005; 65(4):752-9. PubMed ID: 15951134
[TBL] [Abstract][Full Text] [Related]
7. Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases.
Bocci V; Zanardia I; Valacchi G; Borrelli E; Travagli V
Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):127-38. PubMed ID: 26126818
[TBL] [Abstract][Full Text] [Related]
8. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study.
Tylicki L; Niew głowski T; Biedunkiewicz B; Burakowski S; Rutkowski B
Int J Artif Organs; 2001 Feb; 24(2):79-82. PubMed ID: 11256512
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell activity unaffected by ozonated autohemotherapy in patients with end-stage renal disease on maintenance renal replacement therapy.
Biedunkiewicz B; Tylicki L; Rachon D; Hak L; Nieweglowski T; Chamienia A; Debska-Slizien A; Mysliwska J; Rutkowski B
Int J Artif Organs; 2004 Sep; 27(9):766-71. PubMed ID: 15521216
[TBL] [Abstract][Full Text] [Related]
10. Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium.
Tylicki L; Biedunkiewicz B; Nieweglowski T; Chamienia A; Slizien AD; Luty J; Lysiak-Szydlowska W; Rutkowski B
Artif Organs; 2004 Feb; 28(2):234-7. PubMed ID: 14961966
[TBL] [Abstract][Full Text] [Related]
11. Spinal cord stimulation in hemodialysis patients with critical lower-limb ischemia.
Brümmer U; Condini V; Cappelli P; Di Liberato L; Scesi M; Bonomini M; Costantini A
Am J Kidney Dis; 2006 May; 47(5):842-7. PubMed ID: 16632023
[TBL] [Abstract][Full Text] [Related]
12. [Peripheral arterial occlusive disease and its care in hemodialysis patients].
Chen HW; Liu HE
Hu Li Za Zhi; 2011 Apr; 58(2):16-21. PubMed ID: 21455888
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of peripheral artery occlusive disease (PAOD).
Clement DL
Acta Chir Belg; 2000; 100(5):190-3. PubMed ID: 11143319
[TBL] [Abstract][Full Text] [Related]
15. The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs.
Tylicki L; Nieweglowski T; Biedunkiewicz B; Chamienia A; Debska-Slizien A; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Int J Artif Organs; 2003 Apr; 26(4):297-303. PubMed ID: 12757028
[TBL] [Abstract][Full Text] [Related]
16. Alprostadil: modes of actions in peripheral arterial occlusive disease.
Karetova D; Bultas J; Vondracek V; Aschermann M
Am J Ther; 1997; 4(11-12):359-63. PubMed ID: 10423631
[No Abstract] [Full Text] [Related]
17. Thrombolytic therapy for arterial occlusion: a mixed blessing.
Smith CM; Yellin AE; Weaver FA; Li KM; Siegel AE
Am Surg; 1994 May; 60(5):371-5. PubMed ID: 8161090
[TBL] [Abstract][Full Text] [Related]
18. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease.
Giunta R; Coppola A; Luongo C; Sammartino A; Guastafierro S; Grassia A; Giunta L; Mascolo L; Tirelli A; Coppola L
Ann Hematol; 2001 Dec; 80(12):745-8. PubMed ID: 11797116
[TBL] [Abstract][Full Text] [Related]
19. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
Edvinsson LI; Edvinsson ML; Angus Deveber G
Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
[TBL] [Abstract][Full Text] [Related]
20. Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up.
Linnemann B; Prochnow S; Mani H; Schwonberg J; Lindhoff-Last E
Ann Hematol; 2009 Oct; 88(10):979-88. PubMed ID: 19247655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
